IceCure Medical Ltd (NASDAQ:ICCM – Get Free Report) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totalling 196,500 shares, a growth of 26.9% from the June 30th total of 154,900 shares. Approximately 0.9% of the shares of the company are sold short. Based on an average daily volume of 264,000 shares, the short-interest ratio is presently 0.7 days.
Analyst Upgrades and Downgrades
Separately, HC Wainwright reiterated a “buy” rating and set a $3.00 target price on shares of IceCure Medical in a research report on Tuesday, July 2nd.
Read Our Latest Research Report on ICCM
IceCure Medical Stock Performance
IceCure Medical (NASDAQ:ICCM – Get Free Report) last issued its quarterly earnings results on Tuesday, May 28th. The company reported ($0.08) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.08). The firm had revenue of $0.74 million for the quarter, compared to analysts’ expectations of $0.80 million. IceCure Medical had a negative return on equity of 101.66% and a negative net margin of 444.30%. During the same quarter in the previous year, the firm posted ($0.08) EPS. On average, sell-side analysts expect that IceCure Medical will post -0.28 EPS for the current fiscal year.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Further Reading
- Five stocks we like better than IceCure Medical
- What is Put Option Volume?
- Why SoFi Stock is an Unmissable Growth Opportunity
- What Are Dividend Achievers? An Introduction
- Has Micron’s Stock Drop Turned Into A Screaming Buy?
- Short Selling: How to Short a Stock
- Should You Invest in Bonds? Here’s What to Know
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.